EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.2123
https://www.valueinhealthjournal.com/article/S1098-3015(25)02252-1/fulltext
Title :
EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)02252-1&doi=10.1016/j.jval.2025.04.2123
First page :
Section Title :
Open access? :
No
Section Order :
10293